The Severe Acute Respiratory Syndrome Corona Virus (SARS-CoV-2) that causes COVID-19 disease has affected 932,605 individuals and has taken 46,809 lives worldwide. Now, researchers have published a review on the likelihood of survival after SARS-CoV-2 infection. The study titled, “Likelihood of survival of coronavirus disease 2019” is published in the latest issue of The Lancet Infectious Diseases.
India braces for coronavirus onslaught amidst the cries of the poor
Is coronavirus spread through feces?
How (easily) does the novel coronavirus spread?
Hereditary genetic defect linked to medulloblastoma destabilizes protein regulation
Majority of patients with mantle cell lymphoma may benefit from CAR T-cell therapy KTE-X19
What are coronaviruses and COVID-19?
Does the Hand You Write with Affect Brain Development?
What is Acute Respiratory Distress Syndrome (ARDS)?
What are Coronaviruses?
Deliver any compound into any adherent cell - easy and precise solution for your drug assay
Accelerate Your PCR Setup to Combat COVID-19
Controlled Ice Nucleation in the Pharmaceutical Industry
How are Probiotic Formulations Validated?
Marburg Virus Structure and Transmission
Proteoforms in Drug Discovery
The process of organogenesis is the formation of organs during embryonic development. This article looks at the various organs formed.
Progress towards a cure for HIV has been the holy grail for HIV researchers since bursting into the public consciousness in 1981.
Painsomnia is experienced by anyone with a chronic pain causing them to lose sleep, which in turn lowers their tolerance to pain.
Dr Maureen Bunger
Lonza is a large, multinational corporation serving the entire pharmaceutical product development and manufacturing pipeline, from non-clinical research products to final dosage and delivery solutions.
Dr. Dan Lavery
News-Medical speaks to Dr. Dan Lavery about the LouLou Foundation, a non-profit organization dedicated to CDLK5 Deficiency Disorder.
Mark White, Ph.D.
Researchers are in desperate need of single-cell analysis techniques and those that allow the isolation of high-value T-cells for research and development.
Building a Successful Email Campaign for a Scientific Audience
Using Webinars to Tell Science Stories – PART II
Reaching Scientists Through Newsletters